CD73- null mice significantly induce tumor rejection in a variety of syngeneic tumor models (101) and, CD39-null mice were resistant to tumor metastases in B16/F10 mouse melanoma and MCA-38 colorectal models (102). This evidence concerns the gene ENTPD1 and melanoma.